T. Maeda

发表

Combinatory anti-tumor effects of electroporation-mediated chemotherapy and wild-type p53 gene transfer to human esophageal cancer cells.

H. Matsubara, M. Tagawa, S. Sakiyama, 2001, International journal of oncology.

Expression of herpes simplex virus‐thymidine kinase gene controlled by a promoter region of the midkine gene confers selective cytotoxicity to ganciclovir in human carcinoma cells

A. Nakagawara, M. Tagawa, S. Sakiyama, 2001, International journal of cancer.

Inhibition of peritoneal dissemination of colon carcinoma in syngeneic mice immunized with interleukin-2-producing cells.

H. Matsubara, M. Tagawa, S. Sakiyama, 1996, Cancer letters.

Protective immunity is induced in murine colon carcinoma cells by the expression of interleukin-12 or interleukin-18, which activate type 1 helper T cells

Hiroshi Yamamoto, M. Tagawa, S. Sakiyama, 2000, Cancer Gene Therapy.

A minimum c-erbB-2 promoter-mediated expression of herpes simplex virus thymidine kinase gene confers selective cytotoxicity of human breast cancer cells to ganciclovir

H. Matsubara, M. Tagawa, S. Sakiyama, 2001, Cancer Gene Therapy.

Electroporation-mediated transfer of cytokine genes into human esophageal tumors produces anti-tumor effects in mice.

H. Matsubara, M. Tagawa, S. Sakiyama, 2001, Anticancer research.

Transduction of murine colon carcinoma cells with interleukin-15 gene induces antitumor effects in immunocompetent and immunocompromised hosts

M. Tagawa, K. Takenaga, T. Ochiai, 2000, Cancer Gene Therapy.

Transduction of the human deoxycytidine kinase gene in rodent tumor cells induces in vivo growth retardation in syngeneic hosts.

M. Tagawa, H. Namba, S. Sakiyama, 2000, Cancer letters.

Loss of tumorigenicity of human breast cancer cells engineered to produce IL-2, IL-4 or GM-CSF in nude mice.

H. Matsubara, M. Tagawa, S. Sakiyama, 1999, International journal of oncology.